Intrinsic Kidney Pathology in Children and Adolescents Following COVID-19 Vaccination: A Systematic Review

Overview

Journal Children (Basel)

Specialty Health Services

Date 2022 Oct 27

PMID 36291403

Authors

Henry H L Wu

Mohan Shenoy

Philip A Kalra

Rajkumar Chinnadurai

Affiliations

Soon will be listed here.

Abstract

Global COVID-19 vaccination programs for children and adolescents have been developed with international clinical trial data confirming COVID-19 mRNA vaccine safety and efficacy for the pediatric population. The impact of COVID-19 vaccination in the kidneys is thought to be explained by a complex immune-mediated relationship between the two, although the pathophysiological mechanisms of how COVID-19 vaccination potentially induces kidney pathology are not presently well known. Whilst intrinsic kidney pathologies following COVID-19 vaccination have been reported in adults, such cases are only being recently reported with greater frequency in children and adolescents. Conforming to the PRISMA checklist, we conducted a systematic review of the current literature to provide an overview on the range of intrinsic kidney pathologies that have been reported following COVID-19 vaccination in children and adolescents. All English language research articles published on or before 30 June 2022 reporting new-onset or relapsed intrinsic kidney pathology in children or adolescents (≤18 years) following COVID-19 vaccination were selected for qualitative analysis. Out of 18 cases from the 13 published articles selected, there were 10 cases of IgA nephropathy (1 case of rapidly progressive glomerulonephritis requiring acute hemodialysis), 5 cases of minimal change disease (MCD), 1 case of concurrent MCD/tubulointerstitial nephritis (TIN) and 2 cases of TIN. There is no indication currently to avoid vaccination, unless specific circumstances exist, as the benefits of COVID-19 vaccination far outweigh its risks. Concluding the findings from our systematic review based on preliminary evidence, potential adverse effects to the kidney from COVID-19 vaccination affects a small number of children and adolescents among the many who have been vaccinated. There remains good reason at present to support vaccination of children and adolescents with a greater morbidity status, such as those living with preexisting chronic kidney disease. Close observation of all children and adolescents receiving COVID-19 vaccination is recommended, particularly in those with preceding intrinsic kidney pathology to identify risks of relapsed disease.

Citing Articles

IPNA clinical practice recommendations on care of pediatric patients with pre-existing kidney disease during seasonal outbreak of COVID-19.

Alhasan K, Raina R, Boyer O, Koh J, Bonilla-Felix M, Sethi S Pediatr Nephrol. 2024; .

PMID: 39733391 DOI: 10.1007/s00467-024-06565-5.

Editorial on the Special Issue "Advances in Pediatric Acute Kidney Injury".

Rivetti G, Montaldo P, Marzuillo P Children (Basel). 2024; 11(2).

PMID: 38397307 PMC: 10887405. DOI: 10.3390/children11020195.

Kidney complications associated with COVID-19 infection and vaccination in children and adolescents: a brief review.

Baek H, Cho M Clin Exp Pediatr. 2023; 66(10):424-431.

PMID: 37402469 PMC: 10556799. DOI: 10.3345/cep.2023.00738.

COVID-19 Vaccination in Pediatrics: Was It Valuable and Successful?.

Raslan M, Raslan S, Shehata E, Mahmoud A, Sabri N, Alzahrani K Vaccines (Basel). 2023; 11(2).

PMID: 36851090 PMC: 9964251. DOI: 10.3390/vaccines11020214.

References

Ionescu M, Balgradean M, Cirstoveanu C, Balgradean I, Popa L, Pavelescu C . Myopericarditis Associated with COVID-19 in a Pediatric Patient with Kidney Failure Receiving Hemodialysis. Pathogens. 2021; 10(4). PMC: 8073656. DOI: 10.3390/pathogens10040486. View

Yeo S, Cheung C, Barratt J . New insights into the pathogenesis of IgA nephropathy. Pediatr Nephrol. 2017; 33(5):763-777. PMC: 5861174. DOI: 10.1007/s00467-017-3699-z. View

Hogg R . Idiopathic immunoglobulin A nephropathy in children and adolescents. Pediatr Nephrol. 2009; 25(5):823-9. PMC: 2839527. DOI: 10.1007/s00467-008-1096-3. View

Bomback A, Kudose S, DAgati V . De Novo and Relapsing Glomerular Diseases After COVID-19 Vaccination: What Do We Know So Far?. Am J Kidney Dis. 2021; 78(4):477-480. PMC: 8230841. DOI: 10.1053/j.ajkd.2021.06.004. View

Nakazawa E, Uchimura T, Hirai Y, Togashi H, Oyama Y, Inaba A . New-onset pediatric nephrotic syndrome following Pfizer-BioNTech SARS-CoV-2 vaccination: a case report and literature review. CEN Case Rep. 2021; 11(2):242-246. PMC: 8592073. DOI: 10.1007/s13730-021-00656-0. View

Kimmel P, Abraham A, Garrett C . Viral DNA in microdissected renal biopsy tissue from HIV infected patients with nephrotic syndrome. Kidney Int. 1993; 43(6):1347-52. DOI: 10.1038/ki.1993.189. View

Coppo R . Pediatric IgA Nephropathy in Europe. Kidney Dis (Basel). 2019; 5(3):182-188. PMC: 6587208. DOI: 10.1159/000495751. View

Gutierrez S, Dotto B, Petiti J, De Paul A, Dionisio de Cabalier M, Torres A . Minimal change disease following influenza vaccination and acute renal failure: just a coincidence?. Nefrologia. 2012; 32(3):414-5. DOI: 10.3265/Nefrologia.pre2012.Feb.11370. View

Ali K, Berman G, Zhou H, Deng W, Faughnan V, Coronado-Voges M . Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents. N Engl J Med. 2021; 385(24):2241-2251. PMC: 8385554. DOI: 10.1056/NEJMoa2109522. View

10.

Leon-Roman J, Agraz I, Vergara A, Ramos N, Toapanta N, Garcia-Carro C . COVID-19 infection and renal injury: where is the place for acute interstitial nephritis disease?. Clin Kidney J. 2022; 15(9):1698-1704. PMC: 8992323. DOI: 10.1093/ckj/sfac079. View

11.

Weijers J, Alvarez C, Hermans M . Post-vaccinal minimal change disease. Kidney Int. 2021; 100(2):459-461. PMC: 8191283. DOI: 10.1016/j.kint.2021.06.004. View

12.

Gungor T, Yazilitas F, Cakici E, Karakaya D, Bulbul M . Relapse of Idiopathic Nephrotic Syndrome After SARS-CoV-2 Vaccination: Two Case Reports. J Paediatr Child Health. 2022; 58(5):939-940. DOI: 10.1111/jpc.15977. View

13.

Alhosaini M . A Case of Minimal Change Disease after SARS-CoV-2 Vaccination under the Age of 18. Avicenna J Med. 2022; 12(1):31-33. PMC: 9110102. DOI: 10.1055/s-0042-1743209. View

14.

Chakraborty I, Maity P . COVID-19 outbreak: Migration, effects on society, global environment and prevention. Sci Total Environ. 2020; 728:138882. PMC: 7175860. DOI: 10.1016/j.scitotenv.2020.138882. View

15.

Ewer K, Barrett J, Belij-Rammerstorfer S, Sharpe H, Makinson R, Morter R . T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial. Nat Med. 2020; 27(2):270-278. DOI: 10.1038/s41591-020-01194-5. View

16.

Storrar J, Kudose S, Woywodt A . Have we missed AINything? Acute interstitial nephritis in SARS-CoV-2 infection and vaccination. Clin Kidney J. 2022; 15(9):1643-1652. PMC: 9213847. DOI: 10.1093/ckj/sfac147. View

17.

Abramson M, Yu S, Campbell K, Chung M, Salem F . IgA Nephropathy After SARS-CoV-2 Vaccination. Kidney Med. 2021; 3(5):860-863. PMC: 8277542. DOI: 10.1016/j.xkme.2021.05.002. View

18.

Horinouchi T, Nozu K, Iijima K . An updated view of the pathogenesis of steroid-sensitive nephrotic syndrome. Pediatr Nephrol. 2022; 37(9):1957-1965. PMC: 9307535. DOI: 10.1007/s00467-021-05401-4. View

19.

Zhao X, Chen H, Wang H . Glycans of SARS-CoV-2 Spike Protein in Virus Infection and Antibody Production. Front Mol Biosci. 2021; 8:629873. PMC: 8076860. DOI: 10.3389/fmolb.2021.629873. View

20.

Kikuchi Y, Imakiire T, Hyodo T, Higashi K, Henmi N, Suzuki S . Minimal change nephrotic syndrome, lymphadenopathy and hyperimmunoglobulinemia after immunization with a pneumococcal vaccine. Clin Nephrol. 2002; 58(1):68-72. DOI: 10.5414/cnp58068. View